Shoe-sized platform heels to get FDA approval
CHUNKY platform heels may be coming to the U.S. soon.
A startup called Platform Footwear wants to start a small business manufacturing them for the FDA.
Here’s what you need to know.
[MEDIA CONTENT WARNING: This article contains images of children that may be too young to view at a young age.
If you are under age 18, do not view this article.]
Platform Footwear says they’ve already begun manufacturing a small batch of the platform shoes for FDA approval.
The startup says they plan to launch the shoes in the next three to four months.
The FDA requires a small startup to demonstrate the technology and test its product in a randomized clinical trial, which is a trial of a drug to determine whether it works as well as the company’s original drug.
Platform Footwares founder Ryan Mielke told Medical News Now that he plans to ship about 1,000 of the shoes by the end of March.
That’s a small portion of the company.
The shoes are also a step up from the platform that has been popular in Europe.
The company says that they’ve built a more robust, durable platform that’s easier to wear, less likely to slip off and more comfortable to wear.